Merck
CN
  • Involvement of caveolin-1 and CD36 in native LDL endocytosis by endothelial cells.

Involvement of caveolin-1 and CD36 in native LDL endocytosis by endothelial cells.

Biochimica et biophysica acta. General subjects (2019-02-16)
Marie-Christine Gerbod-Giannone, Laurence Dallet, Grégoire Naudin, Annelise Sahin, Marion Decossas, Sylvie Poussard, Olivier Lambert
ABSTRACT

Atherosclerosis is a lipid disease characterized by accumulation of low density lipoprotein (LDL) in the artery wall. The transport of LDL across the endothelium of coronary artery is an initiating event of atherosclerosis, whose mechanism remains poorly understood. In the last decade, it has been shown that in caveolin-1 (Cav-1) deficient mice, LDL infiltration in aorta wall is decreased and CD36 expression in aortas is down-regulated, leading to regression of atherosclerotic lesions. In the present study, we show that native LDL endocytosis is decreased in endothelial cells deficient in Cav-1 or CD36. We demonstrate that Cav-1 and CD36 interact in caveolae-rich domains by different biochemical approaches. In addition, confocal microscopy reveals some colocalization of Cav-1 with CD36. These findings indicate that caveolae and CD36 are involved in native LDL endocytosis and suggest that CD36 might be a good candidate for the transport of native LDL across the endothelium, an early event in atherosclerosis.